Metabolic Effects of Medium-Chain Fatty Acids in Patients With Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Healthy Individuals
Recruiting
N/A
Interventional Study
Medium-chain Acyl-CoA Dehydrogenase Deficiency
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 30 (estimated)
- Sponsor
- University of Copenhagen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this project is to investigate the physiological effects of intake of long-chain fatty acids (LCFA) and medium-chain fatty acids (MCFA) in patients with Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) and healthy individuals
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria MCADD patients:
* Male or female
* Age between 18-80 years old
* Diagnosed Medium-chain acyl-CoA dehydrogenase deficiency (MCADD
Inclusion Criteria Healthy Participants:
* Male or female
* Age between 18-80 years old
Exclusion Criteria both MCADD patients and healthy participa…
Contacts